Status:
UNKNOWN
Relation Between Body Mass Index and Endometrial Thickness
Lead Sponsor:
Aljazeera Hospital
Collaborating Sponsors:
Kasr El Aini Hospital
Conditions:
Postmenopausal Bleeding
Eligibility:
FEMALE
45-75 years
Brief Summary
Postmenopausal Bleeding (PMB) is defined as recurrent attacks of bleeding occurring in women after menopause one year at least after stoppage of cycles \[
Detailed Description
Premalignant lesions and malignant lesions most commonly complex hyperplasia with atypia and carcinoma of the endometrium are present in 1/3 of patients evaluated for postmenopausal bleed-ing, and so ...
Eligibility Criteria
Inclusion
- menopausal women (defined as minimum of 1 year of amenorrhea after the age of 45 years if only the amenorrhea is not related to pregnancy, medication or disease),
Exclusion
- Women with chronic diseases as diabetes mellitus, hypertension or hematological disorders, those received hormone replacement therapy, Tamoxifen or anticoagulant therapy and women with adnexal massed detected by TVUS or apparent causes of bleeding from cervix or vagina e.g. ulcer were excluded.
Key Trial Info
Start Date :
December 2 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 20 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03841916
Start Date
December 2 2018
End Date
March 20 2019
Last Update
March 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Algazeerah and Kasralainy hospital
Giza, Egypt